IOM: International Agreement Needed to Curb False, Unsafe Pharmaceuticals

The Institute of Medicine identified a need for an international agreement to reduce the amount of falsified, substandard and counterfeit pharmaceuticals in a new report.

At the request of the Food and Drug Administration, an IOM committee examined the global effects of falsified, substandard and counterfeit drugs in a report, "Countering the Problem of Falsified and Substandard Drugs."

Click here to read the full report on IOM's recommendations in Becker's ASC Review.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars